Enveric Biosciences, Inc. (ENVB) Revenue & EPS Growth Rates 2026

Growth Analysis - ENVB

Financial Metrics

Revenue Trends

Period:

CAGR Performance

Revenue

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Net Income

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EPS

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EBIT

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EBITDA

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Capex

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Equity

1Y Growth162.28%

5Y CAGR4.11%

10Y CAGR32.08%

Cash Flow

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Historical CAGR

Year	1Y CAGR	2Y CAGR	3Y CAGR	5Y CAGR	10Y CAGR	15Y CAGR	20Y CAGR	30Y CAGR
FY 2025 Dec 31, 2025	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2024 Dec 31, 2024	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2023 Dec 31, 2023	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2022 Dec 31, 2022	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2021 Dec 31, 2021	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2020 Dec 31, 2020	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2019 Dec 31, 2019	-7.2%	-9.4%	3.4%	N/A	N/A	27.0%	17.2%	N/A
FY 2018 Dec 31, 2018	-11.5%	9.1%	39.1%	N/A	N/A	26.5%	17.6%	N/A
FY 2017 Dec 31, 2017	34.4%	74.4%	N/A	N/A	51.7%	24.3%	15.4%	N/A
FY 2016 Dec 31, 2016	126.2%	N/A	N/A	N/A	59.8%	23.1%	15.5%	N/A
FY 2015 Dec 31, 2015	N/A	N/A	N/A	N/A	29.6%	14.1%	13.8%	N/A
FY 2014 Dec 31, 2014	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2013 Dec 31, 2013	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2012 Dec 31, 2012	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2011 Dec 31, 2011	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2010 Dec 31, 2010	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2009 Dec 31, 2009	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2008 Dec 31, 2008	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2007 Dec 31, 2007	125.3%	-20.7%	-12.1%	-16.6%	-12.3%	N/A	N/A	N/A
FY 2006 Dec 31, 2006	-72.1%	-45.1%	-36.0%	-27.0%	-16.5%	N/A	N/A	N/A
FY 2005 Dec 31, 2005	7.8%	-3.1%	-13.7%	-11.5%	-0.1%	N/A	N/A	N/A
FY 2004 Dec 31, 2004	-12.9%	-22.8%	-11.7%	-7.8%	18.7%	N/A	N/A	N/A
FY 2003 Dec 31, 2003	-31.6%	-11.0%	-16.8%	-5.4%	N/A	N/A	N/A	N/A
FY 2002 Dec 31, 2002	15.7%	-8.2%	3.8%	-7.8%	N/A	N/A	N/A	N/A
FY 2001 Dec 31, 2001	-27.2%	-1.7%	-1.5%	-4.5%	N/A	N/A	N/A	N/A
FY 2000 Dec 31, 2000	32.6%	14.5%	-7.5%	12.9%	N/A	N/A	N/A	N/A
FY 1999 Dec 31, 1999	-1.2%	-22.7%	-6.4%	52.7%	N/A	N/A	N/A	N/A
FY 1998 Dec 31, 1998	-39.6%	-8.9%	11.9%	N/A	N/A	N/A	N/A	N/A
FY 1997 Dec 31, 1997	37.4%	52.2%	140.5%	N/A	N/A	N/A	N/A	N/A
FY 1996 Dec 31, 1996	68.7%	218.1%	N/A	N/A	N/A	N/A	N/A	N/A
FY 1995 Dec 31, 1995	500.0%	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 1994 Dec 31, 1994	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Growth Analysis - ENVB

Financial Metrics

Revenue Trends

Period:

CAGR Performance

Revenue

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Net Income

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EPS

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EBIT

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EBITDA

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Capex

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Equity

1Y Growth162.28%

5Y CAGR4.11%

10Y CAGR32.08%

Cash Flow

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Historical CAGR

Year	1Y CAGR	2Y CAGR	3Y CAGR	5Y CAGR	10Y CAGR	15Y CAGR	20Y CAGR	30Y CAGR
FY 2025 Dec 31, 2025	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2024 Dec 31, 2024	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2023 Dec 31, 2023	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2022 Dec 31, 2022	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2021 Dec 31, 2021	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2020 Dec 31, 2020	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2019 Dec 31, 2019	-7.2%	-9.4%	3.4%	N/A	N/A	27.0%	17.2%	N/A
FY 2018 Dec 31, 2018	-11.5%	9.1%	39.1%	N/A	N/A	26.5%	17.6%	N/A
FY 2017 Dec 31, 2017	34.4%	74.4%	N/A	N/A	51.7%	24.3%	15.4%	N/A
FY 2016 Dec 31, 2016	126.2%	N/A	N/A	N/A	59.8%	23.1%	15.5%	N/A
FY 2015 Dec 31, 2015	N/A	N/A	N/A	N/A	29.6%	14.1%	13.8%	N/A
FY 2014 Dec 31, 2014	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2013 Dec 31, 2013	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2012 Dec 31, 2012	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2011 Dec 31, 2011	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2010 Dec 31, 2010	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2009 Dec 31, 2009	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2008 Dec 31, 2008	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2007 Dec 31, 2007	125.3%	-20.7%	-12.1%	-16.6%	-12.3%	N/A	N/A	N/A
FY 2006 Dec 31, 2006	-72.1%	-45.1%	-36.0%	-27.0%	-16.5%	N/A	N/A	N/A
FY 2005 Dec 31, 2005	7.8%	-3.1%	-13.7%	-11.5%	-0.1%	N/A	N/A	N/A
FY 2004 Dec 31, 2004	-12.9%	-22.8%	-11.7%	-7.8%	18.7%	N/A	N/A	N/A
FY 2003 Dec 31, 2003	-31.6%	-11.0%	-16.8%	-5.4%	N/A	N/A	N/A	N/A
FY 2002 Dec 31, 2002	15.7%	-8.2%	3.8%	-7.8%	N/A	N/A	N/A	N/A
FY 2001 Dec 31, 2001	-27.2%	-1.7%	-1.5%	-4.5%	N/A	N/A	N/A	N/A
FY 2000 Dec 31, 2000	32.6%	14.5%	-7.5%	12.9%	N/A	N/A	N/A	N/A
FY 1999 Dec 31, 1999	-1.2%	-22.7%	-6.4%	52.7%	N/A	N/A	N/A	N/A
FY 1998 Dec 31, 1998	-39.6%	-8.9%	11.9%	N/A	N/A	N/A	N/A	N/A
FY 1997 Dec 31, 1997	37.4%	52.2%	140.5%	N/A	N/A	N/A	N/A	N/A
FY 1996 Dec 31, 1996	68.7%	218.1%	N/A	N/A	N/A	N/A	N/A	N/A
FY 1995 Dec 31, 1995	500.0%	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 1994 Dec 31, 1994	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Growth Analysis - ENVB

Financial Metrics

Revenue Trends

CAGR Performance

Revenue

Net Income

EPS

EBIT

EBITDA

Capex

Equity

Cash Flow

Historical CAGR

More on Enveric Biosciences, Inc.

Compare with peers

Explore

Growth Analysis - ENVB

Financial Metrics

Revenue Trends

CAGR Performance

Revenue

Net Income

EPS

EBIT

EBITDA

Capex

Equity

Cash Flow

Historical CAGR

More on Enveric Biosciences, Inc.

Compare with peers

Explore